Annual Accounts Payable
$3.02 M
+$1.64 M+119.00%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual accounts payable is $3.02 million, with the most recent change of +$1.64 million (+119.00%) on December 31, 2022.
- During the last 3 years, ELOX annual accounts payable has risen by +$1.15 million (+61.41%).
- ELOX annual accounts payable is now at all-time high.
Performance
ELOX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.13 M
+$13.00 K+0.42%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly accounts payable is $3.13 million, with the most recent change of +$13.00 thousand (+0.42%) on September 30, 2023.
- Over the past year, ELOX quarterly accounts payable has increased by +$1.54 million (+96.49%).
- ELOX quarterly accounts payable is now at all-time high.
Performance
ELOX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ELOX Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +119.0% | +96.5% |
3 y3 years | +61.4% | +391.2% |
5 y5 years | +97.4% | +319.5% |
ELOX Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +119.0% | at high | +127.3% |
5 y | 5-year | at high | +527.9% | at high | +551.6% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Eloxx Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $3.13 M(+0.4%) |
Jun 2023 | - | $3.12 M(+28.2%) |
Mar 2023 | - | $2.43 M(-19.4%) |
Dec 2022 | $3.02 M(+119.0%) | $3.02 M(+89.3%) |
Sep 2022 | - | $1.59 M(-17.5%) |
Jun 2022 | - | $1.93 M(-33.4%) |
Mar 2022 | - | $2.90 M(+110.5%) |
Dec 2021 | $1.38 M(+186.7%) | $1.38 M(-45.0%) |
Sep 2021 | - | $2.51 M(+24.0%) |
Jun 2021 | - | $2.02 M(+317.3%) |
Mar 2021 | - | $485.00 K(+0.8%) |
Dec 2020 | $481.00 K(-74.3%) | $481.00 K(-24.6%) |
Sep 2020 | - | $638.00 K(-17.1%) |
Jun 2020 | - | $770.00 K(-44.6%) |
Mar 2020 | - | $1.39 M(-25.8%) |
Dec 2019 | $1.87 M(+150.5%) | $1.87 M(+10.9%) |
Sep 2019 | - | $1.69 M(-31.8%) |
Jun 2019 | - | $2.47 M(+10.4%) |
Mar 2019 | - | $2.24 M(+199.9%) |
Dec 2018 | $747.00 K(-51.2%) | $747.00 K(-44.7%) |
Sep 2018 | - | $1.35 M(-35.6%) |
Jun 2018 | - | $2.10 M(-3.5%) |
Mar 2018 | - | $2.17 M(+1900.9%) |
Dec 2017 | $1.53 M(+698.5%) | - |
Sep 2017 | - | $108.60 K(-43.3%) |
Jun 2017 | - | $191.60 K(+75.6%) |
Jun 2017 | $191.60 K(+112.2%) | - |
Mar 2017 | - | $109.10 K(-43.7%) |
Dec 2016 | - | $193.90 K(+33.8%) |
Sep 2016 | - | $144.90 K(+60.5%) |
Jun 2016 | $90.30 K(-61.1%) | $90.30 K(+59.5%) |
Mar 2016 | - | $56.60 K(-10.9%) |
Dec 2015 | - | $63.50 K(-63.6%) |
Sep 2015 | - | $174.40 K(-24.8%) |
Jun 2015 | $232.00 K(-74.3%) | $232.00 K(-64.7%) |
Mar 2015 | - | $656.50 K(-49.7%) |
Dec 2014 | - | $1.31 M(+112.9%) |
Sep 2014 | - | $613.00 K(-32.0%) |
Jun 2014 | $901.20 K(+41.4%) | $901.20 K(+177.4%) |
Mar 2014 | - | $324.90 K(-32.0%) |
Dec 2013 | - | $477.60 K(-52.4%) |
Sep 2013 | - | $1.00 M(+57.5%) |
Jun 2013 | $637.30 K(+7.2%) | $637.30 K(-7.2%) |
Mar 2013 | - | $686.90 K(-36.7%) |
Dec 2012 | - | $1.09 M(+16.5%) |
Sep 2012 | - | $932.20 K(+56.8%) |
Jun 2012 | $594.50 K(+6.3%) | $594.50 K(-26.1%) |
Mar 2012 | - | $804.80 K(+81.3%) |
Dec 2011 | - | $443.80 K(-53.2%) |
Sep 2011 | - | $949.10 K(+69.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | $559.50 K(+0.4%) | $559.50 K(+9.6%) |
Mar 2011 | - | $510.30 K(-18.5%) |
Dec 2010 | - | $626.00 K(+26.6%) |
Sep 2010 | - | $494.40 K(-11.3%) |
Jun 2010 | $557.40 K(-42.9%) | $557.40 K(-60.2%) |
Mar 2010 | - | $1.40 M(+40.4%) |
Dec 2009 | - | $998.20 K(+134.3%) |
Sep 2009 | - | $426.10 K(-56.4%) |
Jun 2009 | $976.70 K(+163.8%) | $976.70 K(+106.8%) |
Mar 2009 | - | $472.40 K(+0.9%) |
Dec 2008 | - | $468.30 K(-6.3%) |
Sep 2008 | - | $499.90 K(+35.0%) |
Jun 2008 | $370.20 K(+238.7%) | $370.20 K(+119.7%) |
Mar 2008 | - | $168.50 K(-69.5%) |
Dec 2007 | - | $552.00 K(+80.5%) |
Sep 2007 | - | $305.80 K(+179.8%) |
Jun 2007 | $109.30 K(+40.7%) | $109.30 K(+24.9%) |
Mar 2007 | - | $87.50 K(-33.0%) |
Dec 2006 | - | $130.60 K(+23.7%) |
Sep 2006 | - | $105.60 K(+35.9%) |
Jun 2006 | $77.70 K(-64.3%) | $77.70 K(-47.9%) |
Mar 2006 | - | $149.10 K(+48.7%) |
Dec 2005 | - | $100.30 K(-28.2%) |
Sep 2005 | - | $139.60 K(-35.8%) |
Jun 2005 | $217.60 K(+215.4%) | $217.60 K(+98.5%) |
Mar 2005 | - | $109.60 K(+19.4%) |
Dec 2004 | - | $91.80 K(-38.3%) |
Sep 2004 | - | $148.90 K(+115.8%) |
Jun 2004 | $69.00 K(+23.0%) | $69.00 K(+178.2%) |
Mar 2004 | - | $24.80 K(-8.1%) |
Dec 2003 | - | $27.00 K(-20.8%) |
Sep 2003 | - | $34.10 K(-39.2%) |
Jun 2003 | $56.10 K(-30.0%) | $56.10 K(-9.7%) |
Mar 2003 | - | $62.10 K(+30.7%) |
Dec 2002 | - | $47.50 K(-81.3%) |
Sep 2002 | - | $253.40 K(+216.0%) |
Jun 2002 | $80.20 K(-52.5%) | $80.20 K(-1.4%) |
Mar 2002 | - | $81.30 K(+223.9%) |
Dec 2001 | - | $25.10 K(-80.6%) |
Sep 2001 | - | $129.30 K(-23.4%) |
Jun 2001 | $168.90 K(-21.3%) | $168.90 K(-1.2%) |
Mar 2001 | - | $171.00 K(+33.1%) |
Dec 2000 | - | $128.50 K(+40.3%) |
Sep 2000 | - | $91.60 K(-57.3%) |
Jun 2000 | $214.70 K(+26.5%) | $214.70 K(-9.1%) |
Mar 2000 | - | $236.20 K(+18.1%) |
Dec 1999 | - | $200.00 K |
Jun 1999 | $169.70 K(+5374.2%) | - |
Jun 1998 | $3100.00(-11.4%) | - |
Jun 1997 | $3500.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual accounts payable year-on-year change?
- What is Eloxx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly accounts payable year-on-year change?
What is Eloxx Pharmaceuticals annual accounts payable?
The current annual accounts payable of ELOX is $3.02 M
What is the all time high annual accounts payable for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual accounts payable is $3.02 M
What is Eloxx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ELOX annual accounts payable has changed by +$1.64 M (+119.00%)
What is Eloxx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ELOX is $3.13 M
What is the all time high quarterly accounts payable for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly accounts payable is $3.13 M
What is Eloxx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ELOX quarterly accounts payable has changed by +$1.54 M (+96.49%)